A Study to Evaluate the Bioavailability of Risankizumab Following Subcutaneous Dosing in Healthy Male Participants
Clinical trial NCT05283694 · COMPLETED
Trial details
- NCT number
- NCT05283694
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-11
- Primary completion
- 2018-06-12
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.